-
公开(公告)号:US11865174B2
公开(公告)日:2024-01-09
申请号:US17367296
申请日:2021-07-02
申请人: Hugh Mason , Andrew Diamos , Mary Pardhe , Brandon Favre
发明人: Hugh Mason , Andrew Diamos , Mary Pardhe , Brandon Favre
IPC分类号: A61K39/12 , A61K39/29 , A61K39/00 , A61K39/295 , A61P31/20 , C12N7/00 , A61K39/145
CPC分类号: A61K39/292 , A61K39/12 , A61K39/145 , A61P31/20 , C12N7/00 , A61K2039/505 , A61K2039/5258 , A61K2039/575 , A61K2039/6056 , A61K2039/70 , C12N2710/20023 , C12N2710/20034 , C12N2710/20071 , C12N2730/10123 , C12N2730/10134 , C12N2730/10171 , C12N2760/16123 , C12N2760/16134 , C12N2760/16171 , C12N2770/24134 , C12N2770/24171
摘要: The disclosure relates to vaccination compositions, for example, against human papillomavirus, Zika virus, and flu virus. The disclosure also relates to vectors for producing the virus-like particles and immune complex platforms of the vaccination compositions.
-
公开(公告)号:US20240216502A1
公开(公告)日:2024-07-04
申请号:US18504962
申请日:2023-11-08
申请人: Hugh MASON , Andrew DIAMOS , Mary PARDHE , Brandon FAVRE
发明人: Hugh MASON , Andrew DIAMOS , Mary PARDHE , Brandon FAVRE
CPC分类号: A61K39/292 , A61K39/12 , A61K39/145 , A61P31/20 , C12N7/00 , A61K2039/505 , A61K2039/5258 , A61K2039/575 , A61K2039/6056 , A61K2039/70 , C12N2710/20023 , C12N2710/20034 , C12N2710/20071 , C12N2730/10123 , C12N2730/10134 , C12N2730/10171 , C12N2760/16123 , C12N2760/16134 , C12N2760/16171 , C12N2770/24134 , C12N2770/24171
摘要: The disclosure relates to vaccination compositions, for example, against human papillomavirus, Zika virus, and flu virus. The disclosure also relates to vectors for producing the virus-like particles and immune complex platforms of the vaccination compositions.
-
公开(公告)号:US20210330785A1
公开(公告)日:2021-10-28
申请号:US17367296
申请日:2021-07-02
申请人: Hugh Mason , Andrew Diamos , Mary Pardhe , Brandon Favre
发明人: Hugh Mason , Andrew Diamos , Mary Pardhe , Brandon Favre
摘要: The disclosure relates to vaccination compositions, for example, against human papillomavirus, Zika virus, and flu virus. The disclosure also relates to vectors for producing the virus-like particles and immune complex platforms of the vaccination compositions.
-
-